GlaxoSmithKline will be speaking at this years' Lyophilisation conference (http://www.smi-
Highlights from the presentation entitled: 3-stage validation approach for Lyophilized products, will include:
Technology Transfer: Evaluation of an existing commercial product
Lyophilisation 2014 will provide a mix of case study led presentations, panel debates and keynote addresses that have been tailored to an audience of professionals involved in PAT implementation, mathematical modelling, design and scale-up, to optimising and validating freeze drying life cycles. The above is just a snap shot of what will be covered at the event. To download a brochure visit www.lyophilisation-
Some of the confirmed attendees so far include: Boehringer Ingelheim, Allembis, Explicat Pharma, MedImmune, Novo Nordisk, GlaxoSmithKline, Norgine, Genzyme, Alexion Pharmaceuticals, Ellab, Ipsen, Ghent University, GEA Pharma Systems, GEA Process Engineering, Bavarian Nordic, Imperial College London plus many more.
For more information and full programme details, please visit:
Lyophilisation 2014: Pharmaceuticals & Biopharmaceuticals
7-8 July, 2014
Marriott Regents Park Hotel, London, UK
For those who are interested there is currently a £100 Early Bird discount ending 30 April available online.
About SMi Group
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-
We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.
For more information on this conference visit www.smi-online.co.uk or alternatively contact John Collins on +44(0) 207 827 6734 or email jcollins@smi-